Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy.

Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy. Acta Haematol. 2018 Mar 29;139(3):171-175 Authors: Schneidewend R, Hosking P, Brazauskas R, Peterson J, Beaudin C, Michaelis L, Atallah E, Hari P, Carlson K PMID: 29597188 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29597188?dopt=Abstract

Source: Acta Haematologica - March 29, 2018 Category: Hematology Authors: Schneidewend R, Hosking P, Brazauskas R, Peterson J, Beaudin C, Michaelis L, Atallah E, Hari P, Carlson K Tags: Acta Haematol Source Type: research

More News: Acute Leukemia | Acute Myeloid Leukemia | Chemotherapy | Hematology | Leukemia